Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Epicel product

Epicel is an autologous treatment for patients with deep dermal or full thickness burns comprising a total body surface area greater than or equal to 30%

Autologous treatment:

Burn repair using a patient's own cells

Up to 144 grafts can be generated and shipped to your facility in a single order

Epicel is derived from two full-thickness biopsies measuring approximately 6cm long by 2cm wide. 

Skin graft dimensions - 6cm x 2cm

Epicel is permanent skin covering for severe burns

Epicel Patient Survival

In the Epicel Clinical Experience databases, 954 adult and pediatric patients with a mean TBSA of 67.5% showed:

84.4% survival¹

The overall survival rate was 84.4% (804/954) at hospital discharge.
The survival rate for pediatric patients was 88.9% and for adults the survival rate was 82.0%.1

Burn patient survival In the 2016 National Burn Repository, 8,870 burn patients with a TBSA of 30%-90% showed: 68% survival2

A single Epicel order can cover an area up to

7200 cm2 Epicel can be ordered for subsequent surgeries without the need for additional biopsies

In the Epicel Clinical Experience databases, 453 patients showed a median take rate at discharge of 75%1

Additional potential benefits of Epicel have been reported:

Rapid Wound
Closure

Epicel may assist in establishing a more rapid wound closure3

Functional
Tissue

Epicel is able to maintain the characteristics of authentic epidermis4

Lower Rate of Infection

By facilitating early wound closure, Epicel was shown to lower the postoperative infection rate5

Play

Dr. Rajiv Sood explains the benefits of Epicel

Play

The Epicel Experience:
One Burn Center's Practice

History of Excellence

Epicel has been used for over 25 years and is manufactured in a state-of-the-art cell culturing facility in Cambridge, Massachusetts

Verified and Validated

Epicel is evaluated for cell sterility and viability, verified by a standard 14-day assessment and then confirmed prior to shipment with 300+ quality control measures

Expert support Provided

Cell Therapy Specialists are dedicated to providing personalized support for healthcare teams using Epicel

Burns constitute a significant expense

Epicel may lower the rate of postoperative infection and metabolic syndrome, which may lead to faster wound closure and reduced overall stay.4

Mean number of hospital days by TBSA in surviving patients2
%TBSA by Hospital Days
Mean cost of hospital stay by TBSA in surviving patients2
%TBSA by Hospital Charges (in thousands)

Specialists are available to answer reimbursement questions about Epicel and the CEA procedure.

Epicel is widely reimbursed and included on a majority of national insurance plans.
Click here to learn more about Epicel reimbursement